Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€11.53

€11.53

-3.720%
-0.425
-3.720%
-

-

 
04.03.26 / Tradegate WKN: A140ML / Name: Novocure / Stock / Biotechnology & Medical Research / Mid Cap /
Your prediction

Novocure Ltd Stock

Heavy losses for Novocure Ltd today as the stock fell by -€0.425 (-3.720%).
Our community identified positive and negative aspects for Novocure Ltd stock for the coming years. 1 users see the criterium "Shareholder structure" as a plus for the Novocure Ltd stock. On the other hand our users think that "EBIT growth" could be a problem in the future.

Pros and Cons of Novocure Ltd in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Novocure Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Novocure Ltd -3.720% -9.288% 17.602% -32.760% 1.676% -83.731% -89.664%
United Therapeutics -0.430% -7.430% 2.958% 44.807% -1.451% 80.111% 214.254%
Iovance Biotherapeutics Inc. 5.570% 13.105% 77.169% -1.216% 54.089% -46.635% -86.241%
Ligand Pharmaceuticals 2.270% 12.500% 7.143% 65.138% 8.434% 154.309% 51.899%